83 related articles for article (PubMed ID: 19796024)
1. Kidney dysfunction induced by protein overload nephropathy reduces serum sulfatide levels in mice.
Li G; Hu R; Kamijo Y; Nakajima T; Aoyama T; Ehara T; Shigematsu H; Kannagi R; Kyogashima M; Hara A
Nephrology (Carlton); 2009 Oct; 14(7):658-62. PubMed ID: 19796024
[TBL] [Abstract][Full Text] [Related]
2. Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides.
Zhang X; Nakajima T; Kamijo Y; Li G; Hu R; Kannagi R; Kyogashima M; Aoyama T; Hara A
Biochem Biophys Res Commun; 2009 Dec; 390(4):1382-8. PubMed ID: 19895791
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a quantitative, qualitative, and high-throughput analysis of sulfatides from small amounts of sera by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
Li G; Hu R; Kamijo Y; Nakajima T; Aoyama T; Inoue T; Node K; Kannagi R; Kyogashima M; Hara A
Anal Biochem; 2007 Mar; 362(1):1-7. PubMed ID: 17254536
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of kidney injuries maintains serum sulfatide levels dependent on hepatic synthetic ability: a possible involvement of oxidative stress.
Sheng X; Nakajima T; Wang L; Zhang X; Kamijo Y; Takahashi K; Tanaka N; Sugiyama E; Kyogashima M; Aoyama T; Hara A
Tohoku J Exp Med; 2012 May; 227(1):1-12. PubMed ID: 22499158
[TBL] [Abstract][Full Text] [Related]
5. Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.
Hu R; Li G; Kamijo Y; Aoyama T; Nakajima T; Inoue T; Node K; Kannagi R; Kyogashima M; Hara A
Glycoconj J; 2007 Dec; 24(9):565-71. PubMed ID: 17657603
[TBL] [Abstract][Full Text] [Related]
6. Imaging of complex sulfatides SM3 and SB1a in mouse kidney using MALDI-TOF/TOF mass spectrometry.
Marsching C; Eckhardt M; Gröne HJ; Sandhoff R; Hopf C
Anal Bioanal Chem; 2011 Jul; 401(1):53-64. PubMed ID: 21359825
[TBL] [Abstract][Full Text] [Related]
7. Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice.
Yamada Y; Harada M; Hashimoto K; Guo R; Nakajima T; Kashihara T; Yamada M; Aoyama T; Kamijo Y
Glycoconj J; 2019 Feb; 36(1):1-11. PubMed ID: 30536036
[TBL] [Abstract][Full Text] [Related]
8. P-selectin mediates metastatic progression through binding to sulfatides on tumor cells.
Garcia J; Callewaert N; Borsig L
Glycobiology; 2007 Feb; 17(2):185-96. PubMed ID: 17043066
[TBL] [Abstract][Full Text] [Related]
9. Renal sulfatides: sphingoid base-dependent localization and region-specific compensation of CerS2-dysfunction.
Marsching C; Rabionet M; Mathow D; Jennemann R; Kremser C; Porubsky S; Bolenz C; Willecke K; Gröne HJ; Hopf C; Sandhoff R
J Lipid Res; 2014 Nov; 55(11):2354-69. PubMed ID: 25267995
[TBL] [Abstract][Full Text] [Related]
10. Serum sulfatide abnormality is associated with increased oxidative stress in hemodialysis patients.
Yuzhe H; Kamijo Y; Hashimoto K; Harada M; Kanno T; Sugiyama E; Kyogashima M; Oguchi T; Nakajima T; Kanno Y; Aoyama T
Hemodial Int; 2015 Jul; 19(3):429-38. PubMed ID: 25645724
[TBL] [Abstract][Full Text] [Related]
11. Selective desorption/ionization of sulfatides by MALDI-MS facilitated using 9-aminoacridine as matrix.
Cheng H; Sun G; Yang K; Gross RW; Han X
J Lipid Res; 2010 Jun; 51(6):1599-609. PubMed ID: 20124011
[TBL] [Abstract][Full Text] [Related]
12. Effects of hypertension and antihypertensive treatments on sulfatide levels in serum and its metabolism.
Guo R; Hu X; Yamada Y; Harada M; Nakajima T; Kashihara T; Yamada M; Aoyama T; Kamijo Y
Hypertens Res; 2019 May; 42(5):598-609. PubMed ID: 30531843
[TBL] [Abstract][Full Text] [Related]
13. Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse.
Yoo KH; Kim YN; Lee MJ; Seong JK; Park JH
Proteomics; 2009 Aug; 9(15):3824-32. PubMed ID: 19637234
[TBL] [Abstract][Full Text] [Related]
14. Sulphatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins and its anticoagulant activity.
Hara A; Taketomi T
Indian J Biochem Biophys; 1993 Dec; 30(6):353-7. PubMed ID: 8005618
[TBL] [Abstract][Full Text] [Related]
15. Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.
Kamijo Y; Wang L; Matsumoto A; Nakajima T; Hashimoto K; Higuchi M; Kyogashima M; Aoyama T; Hara A
Clin Exp Nephrol; 2012 Dec; 16(6):959-67. PubMed ID: 22552383
[TBL] [Abstract][Full Text] [Related]
16. Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice.
Kanbe H; Kamijo Y; Nakajima T; Tanaka N; Sugiyama E; Wang L; Fang ZZ; Hara A; Gonzalez FJ; Aoyama T
Arch Toxicol; 2014 Feb; 88(2):367-79. PubMed ID: 24065054
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric study of N-glycans from serum of woodchucks with liver cancer.
Lattová E; McKenzie EJ; Gruwel ML; Spicer V; Goldman R; Perreault H
Rapid Commun Mass Spectrom; 2009 Sep; 23(18):2983-95. PubMed ID: 19685473
[TBL] [Abstract][Full Text] [Related]
18. The enigmatic role of sulfatides: new insights into cellular functions and mechanisms of protein recognition.
Xiao S; Finkielstein CV; Capelluto DG
Adv Exp Med Biol; 2013; 991():27-40. PubMed ID: 23775689
[TBL] [Abstract][Full Text] [Related]
19. Characterization of galactosyl and lactosyl sulfatide species in human serum by MALDI-TOF mass spectrometry.
Hori A; Yamaura M; Morita S; Uehara T; Honda T; Hidaka H
Ann Clin Biochem; 2019 Sep; 56(5):574-582. PubMed ID: 31037952
[No Abstract] [Full Text] [Related]
20. [Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].
Lakomý R'; Greplová K; Pilný R; Budinská E; Valík D; Poprach A; Nemecek R; Vyzula R
Klin Onkol; 2009; 22(5):228-32. PubMed ID: 19886361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
